8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (May 1, 2013)

Filed May 1, 2013For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on May 1, 2013, primarily to report its financial results for the quarter ended March 31, 2013. The company issued a press release detailing these results, which has been furnished as an exhibit to this filing. Investors should note that this information, while publicly disseminated, is furnished and not deemed "filed" for regulatory purposes, meaning it does not carry the same liabilities as a formally filed document under Section 18 of the Securities Exchange Act of 1934. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release (Exhibit 99.01) for the specifics of the first quarter 2013 performance. This filing serves as a notification and public dissemination mechanism for the company's operational and financial status as of that reporting period, crucial for understanding DexCom's trajectory in the continuous glucose monitoring market.

Key Highlights

  • 1DexCom filed an 8-K on May 1, 2013, announcing its financial results for the first quarter ended March 31, 2013.
  • 2The key financial results and operational data were provided in a press release, furnished as Exhibit 99.01.
  • 3This filing serves as notification of the release of Q1 2013 financial performance data.
  • 4Information furnished under Item 2.02 is not considered 'filed' for Section 18 liability purposes.
  • 5The press release is the primary source for detailed Q1 2013 financial figures and commentary.
  • 6This report indicates DexCom's ongoing public reporting of its financial condition and results of operations.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report DexCom's financial results for the first quarter ended March 31, 2013, and to furnish the accompanying press release that contains these details.

The detailed financial results for the first quarter ended March 31, 2013, are contained within the press release that is furnished as Exhibit 99.01 to this 8-K filing.

No, the information furnished under Item 2.02 of this 8-K, including the press release, is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, and therefore does not subject the company to liabilities under that section.

The filing implies that DexCom was actively reporting its financial performance to the public and the SEC as expected, indicating ongoing business operations and a commitment to transparency regarding its financial condition and results during the first quarter of 2013.